Bumetanide and Jantoven drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bumetanide (bumetanide) and Jantoven (warfarin sodium). Common drug interactions include international normalised ratio increased among females and epistaxis among males.

The phase IV clinical study analyzes what interactions people have when they take Bumetanide and Jantoven. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Bumetanide?

Bumetanide has active ingredients of bumetanide. It is often used in fluid retention. eHealthMe is studying from 20,532 Bumetanide users. Check the latest studies of Bumetanide.

What is Jantoven?

Jantoven has active ingredients of warfarin sodium. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 1,608 Jantoven users. Check the latest studies of Jantoven.



On Jul, 31, 2026

24 people who take Bumetanide and Jantoven together, and have interactions are studied.

Bumetanide and Jantoven drug interactions.

What are the common drug interactions of Bumetanide and Jantoven, by gender? *:

female:

  1. International normalised ratio increased
  2. Arterial insufficiency (lack of enough blood flow through the arteries)
  3. Cardiac failure
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Impaired healing
  6. Agitation (state of anxiety or nervous excitement)
  7. Arthralgia (joint pain)
  8. Bacteraemia (presence of bacteria in the blood)
  9. Blood pressure decreased
  10. Breath sounds

male:

  1. Epistaxis (bleed from the nose)
  2. Drug ineffective
  3. Aggression
  4. Arthralgia (joint pain)
  5. Asthenia (weakness)
  6. Atelectasis (partial or complete collapse of the lung)
  7. Blood glucose increased
  8. Blood urea increased
  9. Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection)
  10. Chest pain

What are the common drug interactions of Bumetanide and Jantoven, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Agitation (state of anxiety or nervous excitement)
  2. Arthralgia (joint pain)
  3. Bacteraemia (presence of bacteria in the blood)
  4. Blood pressure decreased
  5. Breath sounds
  6. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  7. Disease progression
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Ear haemorrhage (bleeding from ear)
  10. Ear infection

60+:

  1. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  2. International normalised ratio increased
  3. Pruritus (severe itching of the skin)
  4. Pulmonary thrombosis (scarring in the lungs)
  5. Abdominal pain upper
  6. Arthralgia (joint pain)
  7. Asthenia (weakness)
  8. Atelectasis (partial or complete collapse of the lung)
  9. Blood glucose increased
  10. Blood urea increased

What are the existing conditions these people have? *

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 16.67%
  2. Cardiac Disorder: 4 people, 16.67%
  3. Diabetic Retinal Oedema (excessive build-up of fluid in the retina due to diabetes): 3 people, 12.50%
  4. Thyroid Diseases: 2 people, 8.33%
  5. Pain: 2 people, 8.33%
  6. Infection: 2 people, 8.33%
  7. High Blood Pressure: 2 people, 8.33%
  8. Depression: 2 people, 8.33%
  9. Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Bumetanide and Jantoven?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Bumetanide and Jantoven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Bumetanide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Jantoven:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Bumetanide and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Jantoven and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on bumetanide and warfarin sodium (the active ingredients of Bumetanide and Jantoven, respectively), and Bumetanide and Jantoven (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: